Secondhand exposure to aerosol from electronic cigarettes: pilot study of assessment of tobacco-specific nitrosamine (NNAL) in urine
| dc.contributor.author | Martínez Sánchez, Jose M. | |
| dc.contributor.author | Ballbè i Gibernau, Montse | |
| dc.contributor.author | Pérez Ortuño, Raúl | |
| dc.contributor.author | Fu Balboa, Marcela | |
| dc.contributor.author | Sureda, Xisca | |
| dc.contributor.author | Pascual, José Antonio | |
| dc.contributor.author | Peruga, Armando | |
| dc.contributor.author | Fernández Muñoz, Esteve | |
| dc.date.accessioned | 2021-02-19T11:34:01Z | |
| dc.date.available | 2021-02-19T11:34:01Z | |
| dc.date.issued | 2019-11-01 | |
| dc.date.updated | 2021-02-19T11:34:02Z | |
| dc.description.abstract | Objective: to assess the levels of a tobacco-specific nitrosamine (NNAL) in non-smokers passively exposed to the second-hand aerosol (SHA) emitted from users of electronic cigarettes (e-cigarettes). Method: we conducted an observational study involving 55 non-smoking volunteers divided into three groups: 25 living at home with conventional smokers, 6 living with e-cigarette users, and 24 in control homes (smoke-free homes). We obtained urine samples from all volunteers to determine NNAL. Results: we detected NNAL in the urine of volunteers exposed to e-cigarettes (median:0.55 pg/mL; interquartile range: 0.26-2.94 pg/mL). The percentage of urine samples with quantifiable NNAL differed significantly among the three groups of homes: 29.2%, 66.7% and 76.0%, respectively (p=0.004). Conclusions: we found NNAL nitrosamine in urine samples from people exposed to SHA from e-cigarettes. However, these results could be confirmed with more studies with larger sample sizes. | eng |
| dc.format.extent | 4 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 689306 | |
| dc.identifier.issn | 0213-9111 | |
| dc.identifier.uri | https://hdl.handle.net/2445/174098 | |
| dc.language.iso | eng | eng |
| dc.publisher | Elsevier | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1016/j.gaceta.2018.07.016 | |
| dc.relation.ispartof | Gaceta Sanitaria, 2019, vol. 33, num. 6, p. 575-578 | |
| dc.relation.uri | https://doi.org/10.1016/j.gaceta.2018.07.016 | |
| dc.rights | cc-by-nc-nd (c) Sociedad Española de Salud Pública y Administración Sanitaria (SESPAS), 2019 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es | |
| dc.source | Articles publicats en revistes (Ciències Clíniques) | |
| dc.subject.classification | Cigarretes electròniques | |
| dc.subject.classification | Marcadors bioquímics | |
| dc.subject.classification | Nitrosamines | |
| dc.subject.other | Electronic cigarettes | |
| dc.subject.other | Biochemical markers | |
| dc.subject.other | Nitrosoamines | |
| dc.title | Secondhand exposure to aerosol from electronic cigarettes: pilot study of assessment of tobacco-specific nitrosamine (NNAL) in urine | eng |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1